Its non-selectivity, considered a clinical drawback, is a scientific advantage: it allows for the isolation of the relative contributions of each MCR subtype using selective antagonism protocols (HS024, JNJ-10229570, MCL-0129)
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients With Type 2 Diabetes: A Report of the American College of Cardiology Solution Set Oversight Committee
Backed by Science: Supported by more than 30 university studies in over 3 decards of scientific research
Blocking was carried out in blocking solution (42 ml PTx.2, 3 ml donkey serum, 5 ml dimethylsulfoxide, 0.02% sodium azide) at 37 C for 2 days
titration strategies, GI side effect management) Cell Metabolism (2022) Coskun T, et al